W5M-28212-98321 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-03-11
Dose 1 — Janssen/Johnson & Johnson
2021-03-12
Registered in v-safe
2021-03-12
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Site: Pain, Swelling · Fever · Headache, Joint pains, Muscle or body aches · Be unable to do your normal daily activities

Adult check-in
2021-03-13
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Site: Pain, Redness, Swelling · Fever · Chills, Joint pains, Muscle or body aches

Adult check-in
2021-03-14
Survey response — days 1–6 daily, dose 1
MedDRA: Hyperhidrosis — Feeling: Good · Site: Pain, Redness, Swelling, Itching

Free text: Sweats

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-03-15
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain, Redness, Swelling, Itching · Fatigue or tiredness

Adult check-in
2021-03-17
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain, Swelling, Itching · None

Adult check-in
2021-03-21
Health check-in — day 7, dose 1
Feeling: Good · Site: Swelling · None

Adult check-in
2021-03-25
Health check-in — day 14, dose 1
Feeling: Good

Adult check-in
2021-04-01
Health check-in — day 21, single dose
Feeling: Good

Adult check-in
2021-04-08
Health check-in — day 28, single dose
Feeling: Good

Adult check-in
2021-04-15
Health check-in — day 35, single dose
Feeling: Good

Adult check-in
2021-04-24
Health check-in — day 42, single dose
Feeling: Good

Adult check-in
2021-06-10
Survey response — 3 months, dose 1
MedDRA: Menstruation delayed — Feeling: Good

Free text: No menstrual cycle since Vaccine

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-09-09
Health check-in — 6 months, dose 1
Feeling: Good

Adult check-in
2022-03-11
Survey response — 12 months, dose 1
MedDRA: Stillbirth — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit, Hospitalization

Free text: Stillbirth 2 weeks after Pfizer booster dose (2nd dose for J&J)

MedDRA releases: 2024-11 · check-in free text available
2022-03-11
Report sent to call center — 12 months, dose 1
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Emergency room or emergency department visit · Hospitalization · 1 call case(s)
2022-03-14
Call 1 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-03-11	Janssen/Johnson & Johnson

Call center

Reported	Outcome	VAERS-related outcome
2022-03-11	Unsuccessful

Free text

Release 5 — days 1–6 daily, dose 1

2021-03-14

Systemic reaction (other): Sweats

Release 9 — 3 months, dose 1

2021-06-10

Symptoms: No menstrual cycle since Vaccine

Release 11 — 12 months, dose 1

2022-03-11

Symptoms: Stillbirth 2 weeks after Pfizer booster dose (2nd dose for J&J)

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Menstruation delayed	✓	✓	✓
SD	Stillbirth	·	·	✓
SRO	Hyperhidrosis	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release